Expanding horizons in theragnostics: from oncology to multidisciplinary applications
La radiologia medica · 2025
DOI: 10.1007/s11547-025-01971-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift La radiologia medica, 2025. Verfasst von Ruicheng Wu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Neoplasms, Theranostic Nanomedicine. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 129 Literaturangaben. Gefördert von: Traditional Chinese medicine of Zhejiang province science and technology plan project, Chinese Scholarship Council, Zhejiang Province Public Welfare Technology Application Research Project in China.
Abstract (Originalsprache)
Theragnostics is the integration of treatment and diagnosis, involving a drug or technology that combines diagnostic imaging with targeted therapy. This approach utilizes imaging to identify specific biological targets, which are then used to deliver therapeutic effects for the benefit of patients. The effectiveness and potential of theragnostics in improving patient outcomes are supported by significant clinical trials and technological innovations. Theragnostics has demonstrated its capacity to deliver targeted and real-time interventions, making it adaptable to diverse clinical domains. Its applications range from visualizing and eradicating tumors to addressing complex neurological disorders and cardiovascular diseases. The integration of nanomaterials and advancements in molecular biology further enhance the capabilities of theragnostics, promising a future where treatments are highly personalized, and diseases are understood and managed at a molecular level previously unattainable. Our comprehensive overview focuses on the current advancements in theragnostics applications across different disease domains. We highlight the role of molecular imaging technologies, such as PET/CT scans, in early diagnosis and treatment. Additionally, we explore the potential of chemokines as molecular imaging targets in systemic inflammatory diseases and central nervous system pathologies. In conclusion, the progression of theragnostics represents a transformative phase in medical practice, providing new avenues for precise treatment and improved patient outcomes. Its multidisciplinary nature and continuous innovation have the potential to profoundly impact the future of medical research and clinical practice, as well as revolutionizing the treatment and management of a wide array of diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People's Republic of China.
- Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
- Department of Urology, Kyung Hee University, Seoul, South Korea.
- Department of Comparative Pathobiology, College of Veterinary Medicine, West Lafayette, USA.
- Purdue Institute for Cancer Research, Purdue University, Westlll Lafayette, IN, USA.
Förderung
- Traditional Chinese medicine of Zhejiang province science and technology plan project
- Chinese Scholarship Council
- Zhejiang Province Public Welfare Technology Application Research Project in China
- Science and Technology Plan Project of Taizhou
- Program for Talents of Chongqing University Three Gorges Hospital
Zitieren
APA
Wu, R., Zhu, W., Shao, F., Wang, J., Li, D., Tuo, Z., Yoo, K. H., Wusiman, D., Shu, Z., Ge, W., Yang, Y., Ke, M., Wei, W., Heavey, S., Cho, W. C., & Feng, D. (2025). Expanding horizons in theragnostics: from oncology to multidisciplinary applications. La radiologia medica. https://doi.org/10.1007/s11547-025-01971-7
Vancouver
Wu R, Zhu W, Shao F, Wang J, Li D, Tuo Z, et al. Expanding horizons in theragnostics: from oncology to multidisciplinary applications. La radiologia medica. 2025. doi:10.1007/s11547-025-01971-7
BibTeX
@article{Wu2025,
author = {Wu, Ruicheng and Zhu, Weizhen and Shao, Fanglin and Wang, Jie and Li, Dengxiong and Tuo, Zhouting and Yoo, Koo Han and Wusiman, Dilinaer and Shu, Ziyu and Ge, Wenjing and Yang, Yubo and Ke, Mang and Wei, Wuran and Heavey, Susan and Cho, William C and Feng, Dechao},
title = {Expanding horizons in theragnostics: from oncology to multidisciplinary applications},
journal = {La radiologia medica},
year = {2025},
doi = {10.1007/s11547-025-01971-7}
}
EUVIMED